Picture of ORYZON Genomics SA logo

ORY — ORYZON Genomics SA News Story

0.000.00%
es flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapSucker Stock

Brief: Oryzon Receives Russian Patent For Vafidemstat Until At Least 2040

Dec 2 (Reuters) - Oryzon Genomics SA  ORY.MC :
    * CONTINUES TO STRENGTHEN ITS PATENT PORTFOLIO FOR
VAFIDEMSTAT
    * PATENT ISSUED BY RUSSIAN PATENT OFFICE RELATES TO
VAFIDEMSTAT
    * ONCE GRANTED, RUSSIAN PATENT WILL NOT EXPIRE UNTIL AT
LEAST 2040
    * PATENT APPLICATIONS ARE ALSO PENDING IN OTHER RELEVANT
MARKETS

Source text: https://tinyurl.com/444647vp
Further company coverage:  ORY.MC 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

Recent news on ORYZON Genomics SA

See all news